Henry J. Fuchs
2010
In 2010, Henry J. Fuchs earned a total compensation of $1.7M as Executive Vice President & Chief Medical Officer at BioMarin Pharmaceutical, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $162,685 |
|---|---|
| Option Awards | $920,860 |
| Salary | $421,032 |
| Stock Awards | $236,610 |
| Other | $6,418 |
| Total | $1,747,605 |
Fuchs received $920.9K in option awards, accounting for 53% of the total pay in 2010.
Fuchs also received $162.7K in non-equity incentive plan, $421K in salary, $236.6K in stock awards and $6.4K in other compensation.
Rankings
In 2010, Henry J. Fuchs' compensation ranked 3,467th out of 10,439 executives tracked by ExecPay. In other words, Fuchs earned more than 66.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,467 out of 10,439 | 67th |
Division Manufacturing | 1,204 out of 3,838 | 69th |
Major group Chemicals And Allied Products | 234 out of 921 | 75th |
Industry group Drugs | 128 out of 680 | 81st |
Industry Pharmaceutical Preparations | 97 out of 481 | 80th |
Source: SEC filing on March 23, 2012.
Fuchs' colleagues
We found four more compensation records of executives who worked with Henry J. Fuchs at BioMarin Pharmaceutical in 2010.
2010
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2010
Stephen Aselage
BioMarin Pharmaceutical
Executive Vice President & Chief Business Officer
2010
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2010
Jeffrey Cooper
BioMarin Pharmaceutical
Chief Financial Officer
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019